Natural History of Asymptomatic Superior Mesenteric Arterial Stenosis.

The aim of this study was to evaluate asymptomatic superior mesenteric artery (SMA) stenosis prognosis according to the presence of coeliac artery (CA) and/or inferior mesenteric artery (IMA) associated stenosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stenosis Constriction, Pathologic Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

Groupement Hospitalier Est

Bron, 69500, France

About this study

BACKGROUND: The benefit of preventive treatment for SMA stenosis remains uncertain. The latest guidelines remain unclear given the lack of data in the literature.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

the presence of coeliac artery (CA) and/or inferior mesenteric artery (IMA) associated stenosis.

Exclusion criteria

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

Development of mesenteric disease defined as acute mesenteric ischemia or chronic mesenteric ischemia.

Time frame: 4 years

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Natural History of Asymptomatic Superior Mesenteric Arterial Stenosis Depends on Celiac and Inferior Mesenteric Arteries Status.

Important dates

Study start: 2017
Primary completion: 2019
Study completion: 2020
First posted: Mar 5, 2021
Registry last updated: Mar 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed